IDEXX Laboratories, Inc. (IDXX)
NASDAQ: IDXX · IEX Real-Time Price · USD
539.93
+0.36 (0.07%)
At close: Mar 28, 2024, 4:00 PM
540.21
+0.28 (0.05%)
After-hours: Mar 28, 2024, 6:47 PM EDT
IDEXX Laboratories Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for IDEXX Laboratories stock have an average target of 588.57, with a low estimate of 460 and a high estimate of 655. The average target predicts an increase of 9.01% from the current stock price of 539.93.
Analyst Consensus: Buy
* Price targets were last updated on Feb 6, 2024.
Analyst Ratings
The average analyst rating for IDXX stock from 7 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Oct '23 | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Buy | 3 | 4 | 4 | 3 | 3 | 3 |
Hold | 2 | 2 | 2 | 3 | 3 | 3 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 6 | 7 | 7 | 7 | 7 | 7 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
JP Morgan | JP Morgan | Buy Maintains $600 → $630 | Buy | Maintains | $600 → $630 | +16.68% | Feb 6, 2024 |
Barclays | Barclays | Buy Maintains $605 → $655 | Buy | Maintains | $605 → $655 | +21.31% | Feb 6, 2024 |
Piper Sandler | Piper Sandler | Buy → Hold Downgrades $525 | Buy → Hold | Downgrades | $525 | -2.77% | Jan 30, 2024 |
Goldman Sachs | Goldman Sachs | Strong Buy Maintains $500 → $650 | Strong Buy | Maintains | $500 → $650 | +20.39% | Jan 17, 2024 |
Piper Sandler | Piper Sandler | Buy Maintains $520 → $525 | Buy | Maintains | $520 → $525 | -2.77% | Nov 6, 2023 |
Financial Forecast
Revenue This Year
4.08B
from 3.66B
Increased by 11.34%
Revenue Next Year
4.49B
from 4.08B
Increased by 10.08%
EPS This Year
11.36
from 10.06
Increased by 12.91%
EPS Next Year
12.97
from 11.36
Increased by 14.19%
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|
High | 4.2B | 4.7B | 5.2B | 5.4B |
Avg | 4.1B | 4.5B | 4.9B | 5.2B |
Low | 3.9B | 4.2B | 4.6B | 4.9B |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|
High | 15.6% | 15.8% | 16.2% | 9.7% |
Avg | 11.3% | 10.1% | 9.9% | 5.4% |
Low | 6.1% | 3.4% | 2.1% | 0.1% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|
High | 11.88 | 13.86 | 15.97 | 17.03 |
Avg | 11.36 | 12.97 | 14.80 | 14.89 |
Low | 10.70 | 11.49 | 12.70 | 12.71 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|
High | 18.0% | 22.0% | 23.1% | 15.1% |
Avg | 12.9% | 14.2% | 14.1% | 0.6% |
Low | 6.4% | 1.1% | -2.1% | -14.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.